Indian Market News

Generic user silhouette icon 5paisa Capital Ltd
  • 8th Jan 2025
  • 3 min read

The New Fund Offer (NFO) for the DSP BSE SENSEX Next 30 Index Fund is scheduled to open on January 10, 2025, and end on January 24, 2025. Subject to tracking inaccuracy, the goal of this open-ended scheme is to produce returns that closely mirror the

Generic user silhouette icon 5paisa Capital Ltd
  • 8th Jan 2025
  • 2 min read

The Securities and Exchange Board of India (SEBI) has instructed several companies preparing for their public listings to disclose any complaints received from whistleblowers, company insiders, or anonymous sources after submitting their draft public

Generic user silhouette icon 5paisa Capital Ltd
  • 8th Jan 2025
  • 2 min read

Nuvama Institutional Equities, has upgraded its rating for Dr. Reddy's Laboratories to "buy" due to its optimistic outlook on the company’s proactive strategies to offset the anticipated impact of Revlimid's patent expiration in 2026. On Tuesday

Generic user silhouette icon 5paisa Capital Ltd
  • 8th Jan 2025
  • 2 min read

In a significant regulatory development, the Securities and Exchange Board of India (SEBI) issued an administrative warning to Ola Electric Mobility on January 7, citing violations of disclosure norms. The electric vehicle giant's shares subsequently

Generic user silhouette icon 5paisa Capital Ltd
  • 8th Jan 2025
  • 1 min read

NTPC Green Energy Ltd., the clean energy subsidiary of NTPC Ltd., India's largest thermal power producer, is set to embark on an ambitious green hydrogen hub project in Pudimadaka, Andhra Pradesh. With an estimated cost of $21 billion (Rs 1.8 trillio

Generic user silhouette icon 5paisa Capital Ltd
  • 8th Jan 2025
  • 2 min read

The National Stock Exchange of India (NSE) has announced the inclusion of six new securities in the Futures and Options (F&O) segment, effective from January 31, 2025. The stocks being added are Castrol India, Gland Pharma, NBCC, Phoenix, Solar I

Generic user silhouette icon 5paisa Capital Ltd
  • 8th Jan 2025
  • 2 min read

International brokerages Jefferies and Bernstein have reiterated their positive outlook on the chemicals-to-retail conglomerate Reliance Industries Ltd. Both firms emphasized their confidence in the company’s growth trajectory despite recent market

Generic user silhouette icon 5paisa Capital Ltd
  • 7th Jan 2025
  • 1 min read

Berger Paints is reportedly making a bid to acquire Akzo Nobel's India stake as the latter’s promoters plan to exit the Indian market by selling their 74.6% shareholding, according to CNBC-TV18 on January 7. Other contenders for the Dulux maker

Generic user silhouette icon 5paisa Capital Ltd
  • 7th Jan 2025
  • 2 min read

One MobiKwik Systems Ltd, a prominent fintech company, reported a net loss of Rs 3.6 crore for the second quarter ending September 2024, primarily due to increased expenses. This marks a reversal from the Rs 5.3 crore net profit posted during the sam

Generic user silhouette icon 5paisa Capital Ltd
  • 7th Jan 2025
  • 2 min read

Larsen & Toubro Ltd (L&T)'s Power Transmission and Distribution (PT&D) segment has secured significant domestic and international contracts for the development of grid infrastructure, strengthening its position as a key player in the glob

Generic user silhouette icon 5paisa Capital Ltd
  • 7th Jan 2025
  • 1 min read

The market regulator has relaxed the rules governing the settlement of brokerage clients' accounts that remain inactive for 30 days. Previously, the Securities and Exchange Board of India (SEBI) mandated brokerages to settle such accounts within t

Generic user silhouette icon 5paisa Capital Ltd
  • 7th Jan 2025
  • 2 min read

Global brokerage firm Jefferies has upgraded its rating for pharmaceutical company Biocon to 'underperform', citing favorable developments related to regulatory approval for its Bengaluru manufacturing facility. In line with this positive sentiment,

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form